Published in Scand J Gastroenterol on January 01, 1997
Free recombination within Helicobacter pylori. Proc Natl Acad Sci U S A (1998) 8.06
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev (2001) 2.97
The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut (2002) 2.67
Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Clin Microbiol Rev (2009) 1.68
Helicobacter Pylori associated global gastric cancer burden. Front Biosci (Landmark Ed) (2009) 1.33
Presence of multiple "Helicobacter heilmannii" strains in an individual suffering from ulcers and in his two cats. J Clin Microbiol (1998) 1.32
"Candidatus Helicobacter heilmannii" from a cynomolgus monkey induces gastric mucosa-associated lymphoid tissue lymphomas in C57BL/6 mice. Infect Immun (2006) 1.16
Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci U S A (2003) 1.16
Identification of non-Helicobacter pylori spiral organisms in gastric samples from humans, dogs, and cats. J Clin Microbiol (2005) 1.15
Rhesus monkey gastric mucins: oligomeric structure, glycoforms and Helicobacter pylori binding. Biochem J (2004) 1.14
Characterization of a culturable "Gastrospirillum hominis" (Helicobacter heilmannii) strain isolated from human gastric mucosa. J Clin Microbiol (1999) 1.12
Role of bacteria in oncogenesis. Clin Microbiol Rev (2010) 1.05
Non-pylori Helicobacter species in humans. Gut (2001) 1.01
Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas. Gut (2003) 1.00
The local immune response of mice after Helicobacter suis infection: strain differences and distinction with Helicobacter pylori. Vet Res (2012) 0.95
Multiplex PCR assay for differentiation of Helicobacter felis, H. bizzozeronii, and H. salomonis. J Clin Microbiol (2004) 0.95
Slaughter pigs are commonly infected by closely related but distinct gastric ulcerative lesion-inducing gastrospirilla. J Clin Microbiol (2000) 0.94
Helicobacter heilmannii gastritis: a histological and immunohistochemical trait. J Clin Pathol (2001) 0.93
Helicobacter suis causes severe gastric pathology in mouse and mongolian gerbil models of human gastric disease. PLoS One (2010) 0.92
Neonatal Fc receptor for IgG (FcRn) expressed in the gastric epithelium regulates bacterial infection in mice. Mucosal Immunol (2011) 0.91
Helicobacter heilmannii-associated gastritis: clinicopathologic findings and comparison with Helicobacter pylori-associated gastritis. J Korean Med Sci (2007) 0.86
Acute phlegmonous gastritis associated with Helicobacter heilmannii infection in a child. Dig Dis Sci (2006) 0.84
Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patients. Aliment Pharmacol Ther (2013) 0.83
In vitro antimicrobial susceptibility testing of Helicobacter felis, H. bizzozeronii, and H. salomonis. Antimicrob Agents Chemother (2005) 0.83
Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase. World J Gastroenterol (2011) 0.82
Diversity in bacterium-host interactions within the species Helicobacter heilmannii sensu stricto. Vet Res (2013) 0.81
Role of γ-glutamyltranspeptidase in the pathogenesis of Helicobacter suis and Helicobacter pylori infections. Vet Res (2015) 0.79
Helicobacter heilmannii sensu stricto-related gastric ulcers: a case report. World J Gastroenterol (2014) 0.78
Helicobacter heilmannii sensu lato: an overview of the infection in humans. World J Gastroenterol (2014) 0.78
Helicobacter suis-Infected Nodular Gastritis and a Review of Diagnostic Sensitivity for Helicobacter heilmannii-Like Organisms. Case Rep Gastroenterol (2015) 0.75
Cloning of Helicobacter suis cholesterol α-glucosyltransferase and production of an antibody capable of detecting it in formalin-fixed, paraffin-embedded gastric tissue sections. Histochem Cell Biol (2017) 0.75
Cellular immune responses in Helicobacter heilmannii infection: evaluation of the role of the host and the bacterium. Dig Dis Sci (2002) 0.75
Effect of Feeding Soy Milk Fermented by Probiotic Bacteria on Some Blood Criteria and Weight of Experimental Animals. Probiotics Antimicrob Proteins (2017) 0.75
Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study). Gut (2009) 5.08
Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology (1997) 4.59
Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst (1997) 3.30
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter (1996) 3.13
Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study. Endoscopy (2013) 2.76
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology (1999) 2.64
Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut (2003) 2.49
The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy (2005) 2.49
EndoResect study: endoscopic full-thickness resection of gastric subepithelial tumors. Endoscopy (2012) 2.44
Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut (2008) 2.20
Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus. Endoscopy (2010) 2.11
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
Effect of inositol-1,4,5-trisphosphate on isolated subcellular fractions of rat pancreas. J Membr Biol (1984) 2.00
Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy (1994) 1.95
Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc (2000) 1.94
The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther (2009) 1.92
Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob Agents Chemother (1999) 1.80
Miami classification for probe-based confocal laser endomicroscopy. Endoscopy (2011) 1.80
Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch (1998) 1.79
Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology (2000) 1.76
Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology (1997) 1.75
Helicobacter and gastric MALT lymphoma. Gut (2002) 1.66
The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol (2001) 1.64
Elimination of Helicobacter pylori under treatment with omeprazole. Z Gastroenterol (1990) 1.60
Animal reservoirs in the transmission of Helicobacter heilmannii. Results of a questionnaire-based study. Scand J Gastroenterol (1998) 1.58
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. Aliment Pharmacol Ther (2003) 1.52
Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. Z Gastroenterol (2003) 1.52
Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol (1992) 1.51
Simple and sensitive detection of mutations in the ras proto-oncogenes using PNA-mediated PCR clamping. Nucleic Acids Res (1996) 1.49
[S3-guidelines--sedation in gastrointestinal endoscopy]. Z Gastroenterol (2008) 1.47
The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer (2000) 1.46
[Helicobacter pylori and stomach carcinoma. Is a preventive intervention study of value?]. Pathologe (1998) 1.45
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study. Eur J Gastroenterol Hepatol (1996) 1.40
Performance, patient acceptance, appropriateness of indications and potential influence on outcome of EUS: a prospective study in 397 consecutive patients. Gastrointest Endosc (1999) 1.40
Eradication of Helicobacter pylori heals atrophic corpus gastritis caused by long-term treatment with omeprazole. Virchows Arch (1999) 1.40
An innovative, safe and sterile sigmoid access (ISSA) for NOTES. Endoscopy (2007) 1.39
[The status of diagnosis of Barrett esophagus. An analysis of 1000 histologically diagnosed cases]. Dtsch Med Wochenschr (1997) 1.39
NOTES for the cardia: antireflux therapy via transluminal access. Endoscopy (2010) 1.38
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol (2001) 1.35
Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol (2001) 1.34
Gastric MALT lymphoma and its relationship to Helicobacter pylori infection: management and pathogenesis of the disease. Microsc Res Tech (2000) 1.29
Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol (2001) 1.28
Helicobacter heilmannii (formerly Gastrospirillum hominis) gastritis: an infection transmitted by animals? Scand J Gastroenterol (1994) 1.26
Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology (1997) 1.22
Nuclear targeting determinants of the phage P1 cre DNA recombinase. Nucleic Acids Res (1999) 1.18
Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int J Cancer (1997) 1.18
Characterization of calcium uptake into rough endoplasmic reticulum of rat pancreas. J Membr Biol (1984) 1.18
Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol (2001) 1.18
Relationships between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion. Z Gastroenterol (1995) 1.18
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer (1998) 1.15
Simultaneous use of laparoscopy and endoscopy for minimally invasive resection of gastric subepithelial masses - analysis of 93 interventions. World J Surg (2008) 1.15
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther (1999) 1.13
Adenoma-carcinoma sequence in the papilla of Vater. Scand J Gastroenterol (1996) 1.13
[Campylobacter pylori and gastritis. Association or induction?]. Pathologe (1989) 1.12
Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer (1999) 1.12
Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases. Virchows Arch (1997) 1.10
Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease. Am J Gastroenterol (2001) 1.10
Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy. Aliment Pharmacol Ther (2007) 1.09
Confocal laser scanning fluorescence microscopy for in vivo determination of microvessel density in Barrett's esophagus. Endoscopy (2008) 1.09
Helicobacter heilmannii and gastric cancer. Lancet (1995) 1.09
Ménétrier's disease and Helicobacter pylori. N Engl J Med (1993) 1.09
The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther (1999) 1.08
Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther (2005) 1.08
Interobserver agreement and accuracy among international experts with probe-based confocal laser endomicroscopy in predicting colorectal neoplasia. Endoscopy (2010) 1.07
Transgastric in vivo histology in the peritoneal cavity using miniprobe-based confocal fluorescence microscopy in an acute porcine model. Endoscopy (2007) 1.06
Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma. Lancet (1999) 1.06
Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc (2000) 1.05
The "ELITE" model: construct validation of a new training system for natural orifice transluminal endoscopic surgery (NOTES). Endoscopy (2009) 1.04
Expression of adhesion molecules on human granulocytes after stimulation with Helicobacter pylori membrane proteins: comparison with membrane proteins from other bacteria. Infect Immun (1995) 1.04
Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritis. Scand J Gastroenterol (1999) 1.04
Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma? J Clin Oncol (1997) 1.03
Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med (1988) 1.01
alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives. Gut (2000) 1.01
What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma? Gastroenterology (1997) 1.01
[Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer. A prospective controlled randomized study]. Dtsch Med Wochenschr (1987) 1.00
Sodium-chloride transport in the thick ascending limb of Henle's loop. Oxygen consumption studies in isolated cells. Pflugers Arch (1981) 1.00
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (1998) 0.99
Colorectal mini-de novo carcinoma: a reality in Germany too. Endoscopy (1995) 0.98
Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology (2000) 0.98
Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial. Aliment Pharmacol Ther (2006) 0.97
The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection. Helicobacter (2000) 0.97
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Aliment Pharmacol Ther (2006) 0.97